Response Monitoring Trial in Patients With Suspected Recurrence of Glioblastoma
- First Posted Date
- 2014-06-27
- Last Posted Date
- 2018-08-17
- Lead Sponsor
- The Methodist Hospital Research Institute
- Target Recruit Count
- 31
- Registration Number
- NCT02176720
- Locations
- 🇺🇸
Houston Methodist Research Institute PET Center, Houston, Texas, United States
A Multimodality Image-guided System for Peripheral Lung Cancer Diagnosis and Therapy
- Conditions
- Interventions
- First Posted Date
- 2014-04-11
- Last Posted Date
- 2021-09-17
- Lead Sponsor
- The Methodist Hospital Research Institute
- Target Recruit Count
- 7
- Registration Number
- NCT02111824
- Locations
- 🇺🇸
MD Anderson Cancer Center Interventional Radiology Dept., Houston, Texas, United States
Single Dose rATG for Renal Allograft Rejection
- First Posted Date
- 2014-04-03
- Last Posted Date
- 2020-09-03
- Lead Sponsor
- The Methodist Hospital Research Institute
- Target Recruit Count
- 30
- Registration Number
- NCT02102854
- Locations
- 🇺🇸
Houston Methodist Hospital, Houston, Texas, United States
Neoadjuvant TDM1 With Lapatinib and Abraxane Compared With Trastuzumab Plus Pertuzumab With Paclitaxel
- Conditions
- Interventions
- First Posted Date
- 2014-02-27
- Last Posted Date
- 2021-09-22
- Lead Sponsor
- The Methodist Hospital Research Institute
- Target Recruit Count
- 32
- Registration Number
- NCT02073487
- Locations
- 🇺🇸
Houston Methodist Hospital, Houston, Texas, United States
🇺🇸Houston Methodist Hospital Sugar Land, Sugar Land, Texas, United States
🇺🇸Houston Methodist Hospital Willowbrook, Houston, Texas, United States
Olive Oil for High Risk Breast Cancer Prevention in Women
- First Posted Date
- 2014-02-21
- Last Posted Date
- 2023-10-10
- Lead Sponsor
- The Methodist Hospital Research Institute
- Target Recruit Count
- 51
- Registration Number
- NCT02068092
- Locations
- 🇺🇸
Houston Methodist Hospital Willowbrook, Houston, Texas, United States
🇺🇸Houston Methodist Hospital, Houston, Texas, United States
🇺🇸Houston Methodist Hospital Sugar Land, Sugar Land, Texas, United States
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- Conditions
- Interventions
- First Posted Date
- 2013-07-31
- Last Posted Date
- 2016-07-01
- Lead Sponsor
- The Methodist Hospital Research Institute
- Target Recruit Count
- 25
- Registration Number
- NCT01913106
- Locations
- 🇺🇸
Houston Methodist, Houston, Texas, United States
Ciprofloxacin for Prevention of BK Infection
- First Posted Date
- 2013-02-12
- Last Posted Date
- 2019-11-13
- Lead Sponsor
- The Methodist Hospital Research Institute
- Target Recruit Count
- 200
- Registration Number
- NCT01789203
- Locations
- 🇺🇸
Houston Methodist Hospital, Houston, Texas, United States
Phase II Trial of Chemotherapy With Temodar With Topotecan for CNS Metastasis of Solid Tumors
- Conditions
- Interventions
- First Posted Date
- 2012-11-29
- Last Posted Date
- 2017-09-19
- Lead Sponsor
- The Methodist Hospital Research Institute
- Registration Number
- NCT01736800
- Locations
- 🇺🇸
Houston Methodist Hospital, Houston, Texas, United States
🇺🇸Methodist Neurological Institute - Department of Neurosurgery, Houston, Texas, United States
MRI-Guided LITT for Treatment Metastatic Brain Tumors
- First Posted Date
- 2012-11-29
- Last Posted Date
- 2018-01-17
- Lead Sponsor
- The Methodist Hospital Research Institute
- Registration Number
- NCT01736722
- Locations
- 🇺🇸
Methodist Neurological Institute - Department of Neurosurgery, Houston, Texas, United States
The Use of CoSeal (Sealant Agent) in Patients During Left Ventricular Assist Device Surgery
- Conditions
- Interventions
- First Posted Date
- 2012-05-24
- Last Posted Date
- 2018-08-31
- Lead Sponsor
- The Methodist Hospital Research Institute
- Target Recruit Count
- 4
- Registration Number
- NCT01605019
- Locations
- 🇺🇸
The Methodist Hospital DeBakey Heart & Vascular Center, Houston, Texas, United States
🇺🇸Texas Heart Institute, Houston, Texas, United States